PubRank

Y Neuzillet

Author PubWeight™ 10.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant 2012 1.74
2 Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer 2012 0.86
3 Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort. World J Urol 2012 0.83
4 [Recommendations Onco-Urology 2010: Kidney cancer]. Prog Urol 2010 0.81
5 Concentration and chain length of polyethylene glycol in islet isolation solution: evaluation in a pancreatic islet transplantation model. Cell Transplant 2012 0.80
6 Effects of nucleotides adenosine monophosphate and adenosine triphosphate in combination with L-arginine on male rabbit corpus cavernosum tissue. Int J Androl 2012 0.80
7 [CCAFU Recommendations 2013: Bladder carcinoma]. Prog Urol 2013 0.79
8 [Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis]. Prog Urol 2013 0.78
9 [Benefit of bladder and upper urinary tract urothelial tumors lymph node dissection: review from the Bladder Cancer Committee of the French National Association of Urology ("CC-AFU Vessie")]. Prog Urol 2012 0.77
10 [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer]. Prog Urol 2012 0.77
11 [Inhibitors of the receptor A for endothelin-1]. Prog Urol 2010 0.76
12 [Urothelial carcinoma in patients under 40 years. Review of the cancer committee of the French Association of Urology]. Prog Urol 2013 0.76
13 [Kidney transplantation in obese recipients: review of the Transplantation Committee of the French Association of Urology]. Prog Urol 2012 0.75
14 [Treatment of metastatic kidney cancer in elderly subjects]. Prog Urol 2009 0.75
15 [CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway]. Prog Urol 2013 0.75
16 [CCAFU Recommendations 2013: Upper urinary tract carcinoma]. Prog Urol 2013 0.75
17 [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]. Prog Urol 2010 0.75
18 [Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology]. Prog Urol 2011 0.75
19 [The 2010 news: highlights of the ASCO-GU, UAE, ASCO, AUA congress…]. Prog Urol 2011 0.75
20 [The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association]. Prog Urol 2011 0.75
21 [Kidney cancer management in 2007: news and recommendations]. Prog Urol 2008 0.75
22 [Is the cytoreductive nephrectomy still necessary in case of metastases?]. Prog Urol 2010 0.75
23 [Do ablative treatments modify the management of kidney tumors in the elderly?]. Prog Urol 2009 0.75
24 [The journey of a molecule, from trials to approval: the specific area of oncology]. Prog Urol 2010 0.75
25 [Demography of residents in urology in France: appraisal and perspectives]. Prog Urol 2008 0.75
26 [Indications for ablative treatment in kidney cancer in the elderly]. Prog Urol 2012 0.75
27 [The place of laparoscopic nephrectomy in the elderly subject]. Prog Urol 2009 0.75
28 [Metastases from squamous cell carcinoma of the penis]. Prog Urol 2008 0.75
29 [Economic evaluation of deflexible ureteroscopy with laser]. Prog Urol 2008 0.75
30 [Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]. Prog Urol 2008 0.75